Question 1

What is the difference between Ozempic® and Wegovy ®?

Accepted Answer

Ozempic® is Ozempic activates GLP-1 receptors to increase insulin secretion, slow gastric emptying, and reduce appetite, thereby lowering blood glucose levels in type 2 diabetes. and is developed by Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.. Wegovy ® is a pharmaceutical product and is developed by Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd..

Question 2

What are Ozempic® and Wegovy ® used for?

Accepted Answer

Ozempic®: Type 2 diabetes mellitus, Cardiovascular risk reduction in patients with type 2 diabetes and established cardiovascular disease. Wegovy ®: no approved indications tracked.

Question 3

Are Ozempic® and Wegovy ® in the same drug class?

Accepted Answer

No — Ozempic® is GLP-1 receptor agonist and Wegovy ® is an uncategorised drug.

	Ozempic®	Wegovy ®
Generic name	Ozempic®	Wegovy ®
Sponsor	Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.	Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Drug class	GLP-1 receptor agonist	—
Molecular target	GLP-1R (glucagon-like peptide-1 receptor)	—
Modality	Small molecule	Small molecule
Phase	FDA-approved	FDA-approved
Therapeutic area	Diabetes	—

Ozempic® vs Wegovy ®

At a glance

Mechanism of action

Approved indications

Ozempic®

Wegovy ®

Common side effects

Ozempic®

Wegovy ®

Further reading

Ozempic®	Ozempic activates GLP-1 receptors to increase insulin secretion, slow gastric emptying, and reduce appetite, thereby lowering blood glucose levels in type 2 diabetes.
Wegovy ®	—